SFL
VRTX icon

Scheeler Financial LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Scheeler Financial LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$942K Buy
+1,802
New +$923K 0.71% 23

Other funds holding VRTX

MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
AF
Avanza Fonder Stockholm, Sweden $5.23B AUM 33.79% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
GGS
Galvin Gaustad & Stein Scottsdale, Arizona $1.33B AUM 13.15% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

Scheeler Financial LLC's VRTX Position: Q3 2026 in Review

Scheeler Financial LLC opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2026: 1,802 shares worth $942K. The stake represents 0.71% of the portfolio and ranks #23 among its holdings.

89 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Scheeler Financial LLC held 1,802 shares of Vertex Pharmaceuticals worth $942K as of Q3 2026.
  • Vertex Pharmaceuticals was a new Scheeler Financial LLC position in Q3 2026.
  • Vertex Pharmaceuticals made up 0.71% of Scheeler Financial LLC's portfolio in Q3 2026, its #23 holding.
  • 89 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Scheeler Financial LLC's 13F filing for Q3 2026, filed 13 Oct 2026.